Gefitinib versus docetaxel in previously treated...

The Lancet 2008 Vol. 372; Iss. 9652

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial

Edward S Kim, Vera Hirsh, Tony Mok, Mark A Socinski, Radj Gervais, Yi-Long Wu, Long-Yun Li, Claire L Watkins, Mark V Sellers, Elizabeth S Lowe, Yan Sun, Mei-Lin Liao, Kell Østerlind, Martin Reck, Alis
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
372
Year:
2008
Language:
english
DOI:
10.1016/s0140-6736(08)61758-4
File:
PDF, 243 KB
english, 2008
Conversion to is in progress
Conversion to is failed